Yoanna Kaneva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yoanna Kaneva has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Oscar
Department of Ophthalmology, Medical Faculty, Medical University of Sofia,1431 Sofia, Bulgaria
2 shared publications - Kalina Mihova
Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University of Sofia, 1431 Sofia, Bulgaria
2 shared publications - Kunka Kamenarova
Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University of Sofia, 1431 Sofia, Bulgaria
2 shared publications - Nevyana Veleva
Department of Ophthalmology, Eye Clinic, University Hospital Alexandrovska, Medical University of Sofia, Sofia, Bulgaria
2 shared publications - Radka Kaneva
Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University of Sofia, 1431 Sofia, Bulgaria
2 shared publications - A. Levi
Department of Ophthalmology, Medical Faculty , Medical University – Sofia , Bulgaria
1 shared publication
Latest Publications
- Open Access
Molecular Spectrum of Syndromic Retinitis Pigmentosa in a Bulgarian Cohort
Background/Objectives: Syndromic retinitis pigmentosa (SRP) presents a significant diagnostic challenge due to marked clinical and genetic heterogeneity. This study aimed to characterize the molecular spectrum of SRP in the previously understudied Bulgarian population, to define its regional allelic architecture and to relate the genetic findings to the main clinical forms of the disease. Methods: A single-centre, retrospective cohort study included 31 patients from 28 unrelated families diagnosed with SRP at the Department of Ophthalmology, University Hospital “Alexandrovska,” Sofia, Bulgaria. The clinical diagnosis was established by ophthalmological and systemic assessment. Molecular diagnosis was established using whole-exome sequencing of nuclear and mitochondrial DNA and/or targeted inherited retinal disease panel sequencing, complemented by copy number variation analysis. Variants were filtered according to rarity and sequencing quality and classified according to ACMG criteria. Results: The underlying etiology was resolved in all 31 patients across ten ciliary and mitochondrial loci (USH2A, USH1C, ADGRV1, CDH23, IFT54, BBS1, BBS4, BBS10, MKKS, and MT-ATP6). Usher syndrome accounted for 77.41% of cases, followed by Bardet–Biedl syndrome (16.13%), Senior-Løken syndrome spectrum (3.23%), and NARP syndrome (3.23%). Six novel variants were identified. A diagnostic latency of approximately 30 years was observed between the clinical diagnosis and the genetic verification, although the first manifestations, mostly extraocular (congenital hearing loss or polydactyly), appeared in childhood. The allelic landscape demonstrated regional enrichment of the Slavic founder USH2A variant p.(Trp3955*) and the p.(Gly3142*) nonsense variant, while the Western European c.2299delG allele was less prominent. Conclusions: This study defines the molecular spectrum of SRP in a Bulgarian cohort and demonstrates a distinct regional allelic architecture. Recognition of early extraocular manifestations and regional variant frequencies may facilitate earlier diagnosis, improve genetic counseling, and support multidisciplinary management and mutation-specific therapeutic approaches.
Open AccessMolecular Spectrum of Syndromic Retinitis Pigmentosa in a Bulgarian Cohort
Background/Objectives: Syndromic retinitis pigmentosa (SRP) presents a significant diagnostic challenge due to marked clinical and genetic heterogeneity. This study aimed to characterize the molecular spectrum of SRP in the previously understudied Bulgarian population, to define its regional allelic architecture and to relate the genetic findings to the main clinical forms of the disease. Methods: A single-centre, retrospective cohort study included 31 patients from 28 unrelated families diagnosed with SRP at the Department of Ophthalmology, University Hospital “Alexandrovska,” Sofia, Bulgaria. The clinical diagnosis was established by ophthalmological and systemic assessment. Molecular diagnosis was established using whole-exome sequencing of nuclear and mitochondrial DNA and/or targeted inherited retinal disease panel sequencing, complemented by copy number variation analysis. Variants were filtered according to rarity and sequencing quality and classified according to ACMG criteria. Results: The underlying etiology was resolved in all 31 patients across ten ciliary and mitochondrial loci (USH2A, USH1C, ADGRV1, CDH23, IFT54, BBS1, BBS4, BBS10, MKKS, and MT-ATP6). Usher syndrome accounted for 77.41% of cases, followed by Bardet–Biedl syndrome (16.13%), Senior-Løken syndrome spectrum (3.23%), and NARP syndrome (3.23%). Six novel variants were identified. A diagnostic latency of approximately 30 years was observed between the clinical diagnosis and the genetic verification, although the first manifestations, mostly extraocular (congenital hearing loss or polydactyly), appeared in childhood. The allelic landscape demonstrated regional enrichment of the Slavic founder USH2A variant p.(Trp3955*) and the p.(Gly3142*) nonsense variant, while the Western European c.2299delG allele was less prominent. Conclusions: This study defines the molecular spectrum of SRP in a Bulgarian cohort and demonstrates a distinct regional allelic architecture. Recognition of early extraocular manifestations and regional variant frequencies may facilitate earlier diagnosis, improve genetic counseling, and support multidisciplinary management and mutation-specific therapeutic approaches.
- Open Access
- 1 June 2026
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 53 (2) , 10-15
Pharmacological, Optical, and Combined Approaches to Myopia Control in Bulgarian Children: A Longitudinal Study
This study presents different treatments, including both medication and glasses, that affect the progression of myopia in children over time. A total of 250 children aged 6 to 16 were evaluated for a period of 36 months. For the purpose of the study, four groups were formed: one group of pediatric patients receiving low-dose atropine (0.01%), another group wearing defocus-modifying glasses, a third group receiving both treatments, and a control group with no treatment. Key biometric indicators, such as axial length, spherical equivalent, and best-corrected visual acuity, were measured at the start of the study and after that every six months. Non-parametric statistical methods were used to compare changes within each group over time and to identify differences between groups. The protocol achieved high data completeness and showed significant changes within the groups (p<0.001). Clear differences between groups appeared after 12 months. The results suggest that combining atropine and defocus lenses is most effective in slowing myopia progression while maintaining good vision.
- 1 June 2026
- Published by Walter de Gruyter GmbH in Acta Medica Bulgarica
- Vol. 53 (2) , 10-15
Open AccessPharmacological, Optical, and Combined Approaches to Myopia Control in Bulgarian Children: A Longitudinal Study
This study presents different treatments, including both medication and glasses, that affect the progression of myopia in children over time. A total of 250 children aged 6 to 16 were evaluated for a period of 36 months. For the purpose of the study, four groups were formed: one group of pediatric patients receiving low-dose atropine (0.01%), another group wearing defocus-modifying glasses, a third group receiving both treatments, and a control group with no treatment. Key biometric indicators, such as axial length, spherical equivalent, and best-corrected visual acuity, were measured at the start of the study and after that every six months. Non-parametric statistical methods were used to compare changes within each group over time and to identify differences between groups. The protocol achieved high data completeness and showed significant changes within the groups (p<0.001). Clear differences between groups appeared after 12 months. The results suggest that combining atropine and defocus lenses is most effective in slowing myopia progression while maintaining good vision.
- Open Access
A Rare Case of Childhood Glaucoma Resulting from Anterior Segment Dysgenesis Associated with a Homozygous Mutation in the CPAMD8 Gene
The term “childhood glaucoma” summarizes a heterogeneous group of diseases characterized by elevated intraocular pressure and associated optic nerve damage. Secondary glaucoma may develop based on non-acquired ocular anomalies, the most common of which are anterior segment dysgeneses. We present a rare case of infantile childhood glaucoma resulting from anterior segment dysgenesis due to a homozygous mutation c.1881delG, p.(Arg627Serfs*6), leading to loss of function in the CPAMD8 gene.
Open AccessA Rare Case of Childhood Glaucoma Resulting from Anterior Segment Dysgenesis Associated with a Homozygous Mutation in the CPAMD8 Gene
The term “childhood glaucoma” summarizes a heterogeneous group of diseases characterized by elevated intraocular pressure and associated optic nerve damage. Secondary glaucoma may develop based on non-acquired ocular anomalies, the most common of which are anterior segment dysgeneses. We present a rare case of infantile childhood glaucoma resulting from anterior segment dysgenesis due to a homozygous mutation c.1881delG, p.(Arg627Serfs*6), leading to loss of function in the CPAMD8 gene.